BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10510788)

  • 1. Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry.
    Celli N; Gallardo AM; Rossi C; Zucchetti M; D'Incalci M; Rotilio D
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):335-43. PubMed ID: 10510788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazole.
    Sparidans RW; Kettenes-van den Bosch JJ; van Tellingen O; Nuyen B; Henrar RE; Jimeno JM; Faircloth G; Floriano P; Rinehart KL; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):43-53. PubMed ID: 10410926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of aplidin, a marine-derived anticancer drug, in human plasma, whole blood and urine by liquid chromatography with electrospray ionisation tandem mass spectrometric detection.
    Celli N; Mariani B; Di Carlo F; Zucchetti M; Lopez-Lazaro L; D'Incalci M; Rotilio D
    J Pharm Biomed Anal; 2004 Feb; 34(3):619-30. PubMed ID: 15127818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatographic assay for the cyclic depsipeptide aplidine, a new marine antitumor drug, in whole blood using derivatization with trans-4'-hydrazino-2-stilbazole.
    Sparidans RW; Schellens JH; López-Lázaro L; Jimeno JM; Beijnen JH
    Biomed Chromatogr; 2004 Jan; 18(1):16-20. PubMed ID: 14872544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of Aplidin, a novel marine-derived antineoplastic agent, in human plasma.
    Yin J; Aviles P; Lee W; Ly C; Floriano P; Ignacio M; Faircloth G
    Rapid Commun Mass Spectrom; 2003; 17(16):1909-14. PubMed ID: 12876692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of dolastatin-10 using HPLC/electrospray ionization mass spectrometry: application in a phase I clinical trial.
    Garteiz DA; Madden T; Beck DE; Huie WR; McManus KT; Abbruzzese JL; Chen W; Newman RA
    Cancer Chemother Pharmacol; 1998; 41(4):299-306. PubMed ID: 9488599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.
    Nuijen B; Bouma M; Henrar RE; Manada C; Bult A; Beijnen JH
    Anticancer Drugs; 1999 Nov; 10(10):879-87. PubMed ID: 10630355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry.
    Zhang W; Zhang C; Liu R; Li H; Zhang J; Mao C; Chen C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):170-7. PubMed ID: 15990371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of felotaxel, a novel anti-cancer drug, in rat plasma and in human plasma and urine.
    Yan L; YanYan J; MinChun C; Jing Y; Ying S; ChengTao L; Jie G; CaiYang L; ZhenXing Z; AiDong W; Yi D
    J Chromatogr Sci; 2013 Mar; 51(3):292-6. PubMed ID: 22933511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the novel depsipeptide anticancer drug Kahalalide F in human plasma by high-performance liquid chromatography under basic conditions coupled to electrospray ionization tandem mass spectrometry.
    Stokvis E; Rosing H; López-Lázaro L; Rodriguez I; Jimeno JM; Supko JG; Schellens JH; Beijnen JH
    J Mass Spectrom; 2002 Sep; 37(9):992-1000. PubMed ID: 12271442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC-MS/MS determination of flavokawain B, a novel anti-tumor chemotherapeutic agent in rat plasma and its application to a pharmacokinetic study in rats.
    Yang X; Zan T; Yan H; Liu B
    Biomed Chromatogr; 2019 Feb; 33(2):e4391. PubMed ID: 30238480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays.
    Geldof AA; Mastbergen SC; Henrar RE; Faircloth GT
    Cancer Chemother Pharmacol; 1999; 44(4):312-8. PubMed ID: 10447579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-high pressure liquid chromatography-tandem mass spectrometry method for the determination of omarigliptin in rat plasma and its application to a pharmacokinetic study in rats.
    Li MF; Hu XX; Ma AQ
    Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28317144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatography with tandem mass spectrometry.
    Bai YL; Yuan HC; Zhang DT; Liu Y; Zhang Y
    J Pharm Biomed Anal; 2016 Jul; 126():98-102. PubMed ID: 27179187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the antitumor agent depsipeptide in plasma by liquid chromatography on serial octadecyl stationary phases.
    Chassaing C; Marshall JL; Wainer IW
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):169-76. PubMed ID: 9869377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
    Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subnanogram API LC/MS/MS quantitation method for depsipeptide FR901228 and its preclinical pharmacokinetics.
    Li Z; Chan KK
    J Pharm Biomed Anal; 2000 Feb; 22(1):33-44. PubMed ID: 10727121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Survey of Didemnin Depsipeptide Production in
    Stankey RJ; Johnson D; Duggan BM; Mead DA; La Clair JJ
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of teniposide in rat plasma by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry after intravenous administration.
    Wang J; Zhang Y; Guan T; Lin X; Tang X; Xu H
    Biomed Chromatogr; 2009 Sep; 23(9):999-1006. PubMed ID: 19382244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.